appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
News & Opinions
Nureca Standalone December 2022 Net Sales at Rs 27.84 crore, down 42.1% Y-o-Y
7 months ago•Moneycontrol
Nureca Consolidated December 2022 Net Sales at Rs 27.79 crore, down 42.2% Y-o-Y
7 months ago•Moneycontrol
Nureca consolidated net profit declines 93.66% in the December 2022 quarter
7 months ago•Business Standard
Sensex shed 236 pts, Nifty at 18,028; Nureca zooms 20%, Coforge and Paytm rise 4% each
8 months ago•Business Today
Nureca shares rebound 25% from day’s low amid heavy volumes, up 17%
8 months ago•Business Today
Agri-Tech (India) Ltd leads gainers in ‘B’ group
8 months ago•Business Standard
Bharat Immunological & Biological Corporation Ltd leads gainers in ‘B’ group
9 months ago•Business Standard